Status:
UNKNOWN
Molecular Imaging of Pituitary Adenomas
Lead Sponsor:
Cardiff University
Collaborating Sponsors:
Cardiff and Vale University Health Board
Conditions:
Pituitary Adenoma
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Background: Pituitary adenomas affect 10% of the population. Surgery offers the most cost-effective treatment modality but cure rates are only 40-70%, in part due to the limitations of Magnetic Resona...
Detailed Description
Aim: In this proof-of-concept study, the investigators will seek to establish whether imaging changes in Dopaminergic transmission and receptor function has the potential to improve localisation and m...
Eligibility Criteria
Inclusion
- Confirmed pituitary adenoma for whom pituitary imaging is indicated as part of standard clinical management
Exclusion
- Pregnancy, breastfeeding and any contraindications to MRI or intravenous contrast administration
Key Trial Info
Start Date :
April 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03815838
Start Date
April 23 2018
End Date
December 1 2020
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Wales
Cardiff, United Kingdom, CF14 4XW